Πέμπτη 20 Δεκεμβρίου 2018

Keytruda Seen as ‘Kinder’ and Superior to Standard Therapies for Advanced Head and Neck Cancer Patients in Phase 3 Trial - Immuno-Oncology News

Keytruda Seen as 'Kinder' and Superior to Standard Therapies for Advanced Head and Neck Cancer Patients in Phase 3 Trial  Immuno-Oncology News

Treatment with Keytruda (pembrolizumab) extends in clinically meaningful ways the lives of people with recurrent or metastatic head and neck squamous cell ...



from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2EwZJR9

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.